Zhang Xiaoliang's research team was awarded Wiley China Open Scientific High Contribution Author

EssenceAfter the results of the research were published, they immediately received widespread attention from scholars around the world. They received 1141 downloads within three months after the release.In the first quarter of 2022, the honor of "Wiley China Open Scientific Contribution Author" was honored.The first author of this article Wang Bin, Deputy Chief Physician, and the author of Zhang Xiaoliang.

Director Zhang Xiaoliang said that the professional team of cardiovascular diseases in the Department of Kidney Department of CUHK Hospital has been committed to the prevention and treatment of cardiovascular disease in patients with dialysis patients, and has achieved a series of results.The application and research results of the new drug SACUBITRIL/VALSARTAN in hemodialysis refractory hypertension patients add data support to hypertension indications.(Wang Qian Cheng Shouqin)

- END -